4329.0.00.006 - Mortality of People Using Mental Health Services and Prescription Medications, Analysis of 2011 data  
ARCHIVED ISSUE Released at 11:30 AM (CANBERRA TIME) 08/09/2017  First Issue
   Page tools: Print Print Page Print all pages in this productPrint All



CodeMedication groupsCodeMedication subgroup

N05Psycholeptics - A group of drugs that tranquillises (central nervous system depressants)

N05AAntipsychotics - drugs used to treat symptoms of psychosis (a severe mental disorder characterised by loss of contact with reality, delusions and hallucinations), common in conditions such as schizophrenia, mania and delusional disorderN05AAPhenothiazines with aliphatic side-chain
N05ABPhenothiazines with piperazine structure
N05ACPhenothiazines with piperidine structure
N05ADButyrophenone derivatives
N05AEIndole derivatives
N05AFThioxanthene derivatives
N05AHDiazepines, oxazepines, thiazepines and oxepines
N05AXOther antipsychotics

N05BAnxiolytics - drugs prescribed to treat symptoms of anxiety.N05BABenzodiazepine derivatives

N05CHypnotics and sedatives - hypnotic drugs are used to induce sleep and treat severe insomnia. Sedative drugs are prescribed to reduce excitability or anxiety. N05CDBenzodiazepine derivatives

N06Psychoanaleptics - A group of drugs that stimulates the mood (central nervous system stimulants)

N06AAntidepressants - drugs used to treat the symptoms of clinical depression.N06AANon-selective monoamine reuptake inhibitors
N06ABSelective serotonin reuptake inhibitors
N06AFMonoamine oxidase inhibitors, non-selective
N06AGMonoamine oxidase A inhibitors
N06AXOther antidepressants

N06BPsychostimulants, agents used for ADHD and nootropics - agents used for attention-deficit hyperactivity disorder and to improve impaired cognitive abilities (nootropics).N06BACentrally acting sympathomimetics

Source: Australian Institute of Health and Welfare, 2014, 'Medicare-subsidised mental health-related prescriptions', viewed 13 August 2014, < https://mhsa.aihw.gov.au/services/medicare/>